ClinicalTrials.Veeva

Menu

A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD

Wave Neuroscience logo

Wave Neuroscience

Status

Completed

Conditions

Autistic Disorder

Treatments

Other: MeRT Efficacy Chart Review

Study type

Observational

Funder types

Industry

Identifiers

NCT02758496
MeRT-016

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) on subjects with Autism Spectrum Disorder (ASD).

Full description

This is a retrospective chart review of 200 consecutive charts of subjects ages 2-20 years old seen at the Brain Treatment Center between 2010 and 2015. The review is designed to evaluate the safety and efficacy of Magnetic Electroencephalogram/Electrocardiogram(EEG/ECG)-Guided Resonance Therapy (MeRT) on subjects with Autism Spectrum Disorder (ASD).

Enrollment

141 patients

Sex

All

Ages

2 to 20 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Must have completed a baseline EEG at the Brain Treatment Center (BTC)

  2. Age between 2 and 20 years old at initial visit

  3. Must have a diagnosis of ASD according to the prevailing standard at that time (i.e., Diagnostic and Statistical Manual-IV (DSM-IV)) (ASD Group only)

  4. Must have received Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) for more than (5) sessions (ASD Group only)

    Exclusion Criteria:

  5. Clinically significant abnormality or clinically significant unstable medical condition during treatment that in the Investigator's judgment may have may limited interpretation of the results.

Trial design

141 participants in 2 patient groups

ASD Subjects
Description:
Approximately two hundred (200) male and female subjects of any ethnic background between the ages of 2-20 years old seen at the Brain Treatment Center (BTC) between 2010 and 2015.
Treatment:
Other: MeRT Efficacy Chart Review
Healthy Controls
Description:
Twenty (20) male and female subjects of any ethnic background between the ages of 2-20 years old with 'neurotypical' EEGs will be selected for comparison to the ASD group
Treatment:
Other: MeRT Efficacy Chart Review

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems